Literature DB >> 17237793

Dickkopf-1 is a master regulator of joint remodeling.

Danielle Diarra1, Marina Stolina, Karin Polzer, Jochen Zwerina, Michael S Ominsky, Denise Dwyer, Adelheid Korb, Josef Smolen, Markus Hoffmann, Clemens Scheinecker, Desiree van der Heide, Robert Landewe, Dave Lacey, William G Richards, Georg Schett.   

Abstract

Degenerative and inflammatory joint diseases lead to a destruction of the joint architecture. Whereas degenerative osteoarthritis results in the formation of new bone, rheumatoid arthritis leads to bone resorption. The molecular basis of these different patterns of joint disease is unknown. By inhibiting Dickkopf-1 (DKK-1), a regulatory molecule of the Wnt pathway, we were able to reverse the bone-destructive pattern of a mouse model of rheumatoid arthritis to the bone-forming pattern of osteoarthritis. In this way, no overall bone erosion resulted, although bony nodules, so-called osteophytes, did form. We identified tumor necrosis factor-alpha (TNF) as a key inducer of DKK-1 in the mouse inflammatory arthritis model and in human rheumatoid arthritis. These results suggest that the Wnt pathway is a key regulator of joint remodeling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17237793     DOI: 10.1038/nm1538

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  442 in total

Review 1.  Skeletal complications of rheumatoid arthritis.

Authors:  L Heinlen; M B Humphrey
Journal:  Osteoporos Int       Date:  2017-08-04       Impact factor: 4.507

2.  Generation and selection of novel fully human monoclonal antibodies that neutralize Dickkopf-1 (DKK1) inhibitory function in vitro and increase bone mass in vivo.

Authors:  Helmut Glantschnig; Richard A Hampton; Ping Lu; Jing Z Zhao; Salvatore Vitelli; Lingyi Huang; Peter Haytko; Tara Cusick; Cheryl Ireland; Stephen W Jarantow; Robin Ernst; Nan Wei; Pascale Nantermet; Kevin R Scott; John E Fisher; Fabio Talamo; Laura Orsatti; Alfred A Reszka; Punam Sandhu; Donald Kimmel; Osvaldo Flores; William Strohl; Zhiqiang An; Fubao Wang
Journal:  J Biol Chem       Date:  2010-10-07       Impact factor: 5.157

3.  Rheumatoid arthritis: Repair of erosion in RA--shifting the balance to formation.

Authors:  Ellen M Gravallese; Nicole C Walsh
Journal:  Nat Rev Rheumatol       Date:  2011-09-20       Impact factor: 20.543

Review 4.  New targets for intervention in the treatment of postmenopausal osteoporosis.

Authors:  E Michael Lewiecki
Journal:  Nat Rev Rheumatol       Date:  2011-09-20       Impact factor: 20.543

Review 5.  Update on Wnt signaling in bone cell biology and bone disease.

Authors:  David G Monroe; Meghan E McGee-Lawrence; Merry Jo Oursler; Jennifer J Westendorf
Journal:  Gene       Date:  2011-11-03       Impact factor: 3.688

6.  Autoimmunity's next top models.

Authors:  Hartmut Wekerle; Alexander Flügel; Lars Fugger; Georg Schett; David Serreze
Journal:  Nat Med       Date:  2012-01-06       Impact factor: 53.440

7.  Dual regulation of metalloproteinase expression in chondrocytes by Wnt-1-inducible signaling pathway protein 3/CCN6.

Authors:  Natasha Baker; Paul Sharpe; Kirsty Culley; Miguel Otero; Damon Bevan; Peter Newham; Wendy Barker; Kristen M Clements; Caroline J Langham; Mary B Goldring; Jelena Gavrilović
Journal:  Arthritis Rheum       Date:  2012-07

8.  Can rheumatoid arthritis ever cease to exist: a review of various therapeutic modalities to maintain drug-free remission?

Authors:  Di Liu; Na Yuan; Guimei Yu; Ge Song; Yan Chen
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

Review 9.  WNT signaling in bone homeostasis and disease: from human mutations to treatments.

Authors:  Roland Baron; Michaela Kneissel
Journal:  Nat Med       Date:  2013-02-06       Impact factor: 53.440

10.  Chondrocyte β-catenin signaling regulates postnatal bone remodeling through modulation of osteoclast formation in a murine model.

Authors:  Baoli Wang; Hongting Jin; Mei Zhu; Jia Li; Lan Zhao; Yejia Zhang; Dezhi Tang; Guozhi Xiao; Lianping Xing; Brendan F Boyce; Di Chen
Journal:  Arthritis Rheumatol       Date:  2014-01       Impact factor: 10.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.